Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luveris addition in ART ovarian stimulation
NCT01121991Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Sep 2004
- Primary completion
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label, single-arm trial of lutropin alfa in female infertility, sponsored by EMD Serono. Primary endpoints: Mean Number of Metaphase II Oocytes Per Participant Who Underwent Ovum Pick up for Intra-cytoplasmic Sperm Injection (ICSI) and Mean Number of Mature Oocytes Per Participant Who Underwent Ovum Pick up for In Vitro Fertilization (IVF). Started Sep 2004; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT01121991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121991.